Meag Munich Ergo Kapitalanlagegesellschaft MBH raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 41.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,549 shares of the medical equipment provider’s stock after buying an additional 1,622 shares during the quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH’s holdings in Intuitive Surgical were worth $2,608,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors also recently added to or reduced their stakes in ISRG. Moody National Bank Trust Division bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $38,000. Cornerstone Advisors Inc. boosted its stake in shares of Intuitive Surgical by 32.3% during the 3rd quarter. Cornerstone Advisors Inc. now owns 123 shares of the medical equipment provider’s stock worth $71,000 after acquiring an additional 30 shares during the period. Shine Investment Advisory Services Inc. bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $75,000. Arrow Financial Corp bought a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $115,000. Finally, JNBA Financial Advisors bought a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $115,000. 96.78% of the stock is currently owned by hedge funds and other institutional investors.
ISRG stock opened at $533.47 on Thursday. The company has a market capitalization of $61.79 billion, a PE ratio of 56.21, a price-to-earnings-growth ratio of 3.91 and a beta of 1.12. Intuitive Surgical, Inc. has a 12-month low of $393.57 and a 12-month high of $581.12.
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 24th. The medical equipment provider reported $2.96 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.07 by ($0.11). Intuitive Surgical had a net margin of 30.29% and a return on equity of 18.11%. The business had revenue of $1.05 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the prior year, the company earned $2.54 earnings per share. The business’s revenue was up 17.3% on a year-over-year basis. On average, analysts anticipate that Intuitive Surgical, Inc. will post 10.07 EPS for the current year.
In other Intuitive Surgical news, CEO Gary S. Guthart sold 28,085 shares of the stock in a transaction on Monday, December 3rd. The stock was sold at an average price of $542.78, for a total transaction of $15,243,976.30. Following the completion of the transaction, the chief executive officer now directly owns 368,704 shares of the company’s stock, valued at $200,125,157.12. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Gary S. Guthart sold 28,152 shares of the firm’s stock in a transaction on Monday, February 4th. The stock was sold at an average price of $520.47, for a total value of $14,652,271.44. Following the completion of the transaction, the chief executive officer now directly owns 379,452 shares of the company’s stock, valued at $197,493,382.44. The disclosure for this sale can be found here. Over the last three months, insiders have sold 66,512 shares of company stock valued at $35,318,293. 2.20% of the stock is owned by corporate insiders.
A number of research firms have commented on ISRG. Zacks Investment Research lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Wednesday, January 2nd. Citigroup reduced their price target on Intuitive Surgical from $601.00 to $560.00 and set a “buy” rating on the stock in a research report on Wednesday, January 2nd. Cantor Fitzgerald restated a “buy” rating and set a $620.00 target price on shares of Intuitive Surgical in a research report on Friday, October 19th. Piper Jaffray Companies upped their target price on Intuitive Surgical to $613.00 and gave the company an “overweight” rating in a research report on Friday, October 19th. Finally, Royal Bank of Canada reaffirmed a “hold” rating and set a $560.00 price target on shares of Intuitive Surgical in a research note on Friday, October 19th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $566.40.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Further Reading: Quiet Period Expirations
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.